I took a very quick look at the information available in Bosnian language-- didn't find too much solid stuff out there-- it looks like Phase II was completed in December. The drug is an immunomodulatory agent of some sort (sorry, don't speak either English or any other language well enough to understand dr-speak). It is administered sub-Q; was tested on 60 RR (I think) patients, half of whom were controls. Again, all I was able to find are references to "many" of them experiencing improvement in MRI and EDSS, as well as in bladder, bowel control, eye function, coordination etc. Looks like it's proceeding to Phase III; some of the testing centers either were or will be (I couldn't understand that part) in Germany.